Omeprazole: Gastrin and gastric data

[1]  C. Wilder-Smith,et al.  Tolerance to oral H2-receptor antagonists , 1990, Digestive Diseases and Sciences.

[2]  P. Infante,et al.  Prevention versus chemophobia: a defence of rodent carcinogenicity tests , 1991, The Lancet.

[3]  R. Berlin.  Omeprazole. Gastrin and gastric endocrine cell data from clinical studies. , 1991, Digestive diseases and sciences.

[4]  W. Creutzfeldt,et al.  Session 6: Is Hypergastrinaemia Dangerous to Man? , 1991 .

[5]  W. Creutzfeldt,et al.  Is hypergastrinaemia dangerous to man? , 1991, Scandinavian journal of gastroenterology. Supplement.

[6]  L. Findley,et al.  Community care and patients with progressive conditions , 1990 .

[7]  R. Hunt.  Acid suppression. , 1990, BMJ.

[8]  J. Jansen,et al.  Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. , 1990, Gastroenterology.

[9]  P. Maurel,et al.  Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. , 1990, Gastroenterology.

[10]  W. Creutzfeldt,et al.  Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine. , 1990, Digestion.

[11]  G. Mela,et al.  Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study. , 1989, Scandinavian journal of gastroenterology.

[12]  F. Macdonald,et al.  BINDING ASSAY TO PREDICT RESPONSE TO H2-ANTAGONISTS , 1989, The Lancet.

[13]  R. Pounder,et al.  Twenty‐four‐hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole , 1987, Alimentary pharmacology & therapeutics.

[14]  R. Pounder,et al.  Twenty‐four‐hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia , 1987, Alimentary pharmacology & therapeutics.

[15]  E. C. Wood,et al.  Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. , 1984, British medical journal.